货号：UP536480291
| 产品信息 | |
| 产品名称： | Rigosertib sodium |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 592542-60-4 |
| 分子式： | C21H24NNaO8S |
| 分子量： | 473.47 |
| MDL NO： | - |
| 标准纯度： | 97% (UP536480291) |
| 沸点： | - |
| 储存： | (UP536480291) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
Trametinib
UP840491517871700-17-3
JNJ-63533054
UP3922382801802326-66-4
2,3,3-Trimethylindolenine
UP6767009461640-39-7
Defactinib
UP4404376381073154-85-4
ADAMTS Inhibitor C7
UP2800538801607004-34-1
GLPG0187
UP1235360561320346-97-1
KY 12420
UP65007770119545-26-7
Streptozocin
UP28167792118883-66-4
Mdivi-1
UP752526823338967-87-6
Cyclo(-RGDfK)
UP590379412161552-03-0
LB-100
UP1574712941632032-53-1
MI-2
UP9081447291271738-62-5
TACE Inhibitor C3
UP6013805971219812-22-2
Dinaciclib
UP634161437779353-01-4
Ispinesib
UP436070362336113-53-2
Compound 401
UP354549706168425-64-7
Loteprednol etabonate
UP76115004082034-46-6
Fadrozole
UP888507678102676-47-1
ME0328
UP9322263841445251-22-8
Quizartinib
UP405321950950769-58-1
Pacritinib
UP481962740937272-79-2
GSK-LSD1 Dihydrochloride
UP6857913871821798-25-7
XL413 hydrochloride
UP2878882541169562-71-3
Cyclo(RGDyK)
UP649763393250612-42-1
Pedalitin
UP89135760122384-63-0
FRAX1036
UP2016106031432908-05-8
Sirtinol
UP129370095410536-97-9
ORM-15341
UP9468761041297537-33-7
Temozolomide
UP53606604685622-93-1
NU-7200
UP688916522842122-14-9
Rigosertib Sodium(Random Configuration)
UP7228434031225497-78-8
BI-2536
UP665967775755038-02-9
BPR1J-097
UP4726553421327167-19-0
JNK Inhibitor IX
UP562739609312917-14-9
(E)-5-(2-Bromovinyl)-2'-deoxyuridine
UP96995090769304-47-8
Cilengitide
UP469854353188968-51-6
AK-7
UP291318061420831-40-9
Leupeptin hemisulfate
UP593182986103476-89-7
Equol
UP927055009531-95-3
PF-04929113 Mesylate
UP7554425631173111-67-5
2-Bromobiphenyl
UP45627479302052-07-5
Rigosertib sodium
UP536480291592542-60-4